Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Nefrología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
Belatacept Conversion Trial in Renal Transplantation
INTERVENTIONAL
Inicio: 1 de ene de 2007
ID: NCT00402168
Completado
ClinicalTrials.gov
Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection
OBSERVATIONAL
Inicio: 1 de ene de 2010
ID: NCT01869010
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00549757
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Budoprutug (TNT119) in Subjects With Primary Membranous Nephropathy (PMN)
INTERVENTIONAL
Inicio: 25 de ago de 2025
ID: NCT07096843
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy at Risk of Progressing to End-stage Renal Disease (NefIgArd)
INTERVENTIONAL
Inicio: 5 de sept de 2018
ID: NCT03643965
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of ALXN2050 in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
INTERVENTIONAL
Inicio: 14 de ene de 2022
ID: NCT05097989
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Open-label, Randomized, Noninferiority Trial of Subcutaneous Formulation of Nivolumab Versus Intravenous Nivolumab in Participants With Advanced or Metastatic Clear Cell Renal Cell Carcinoma Who Have Received Prior Systemic Therapy
INTERVENTIONAL
Inicio: 21 de may de 2021
ID: NCT04810078
Reclutando
Fase 3
ClinicalTrials.gov
An Open-Label, Multicenter, Randomized Phase 3 Study Evaluating the Efficacy and Safety of Felzartamab in Participants With Primary Membranous Nephropathy (PMN) [PROMINENT]
INTERVENTIONAL
Inicio: 22 de may de 2025
ID: NCT06962800
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.
INTERVENTIONAL
Inicio: 15 de mar de 2022
ID: NCT05248646
Reclutando
Fase 2
ClinicalTrials.gov
A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, and Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
INTERVENTIONAL
Inicio: 19 de dic de 2024
ID: NCT06500702
Completado
Fase 4
ClinicalTrials.gov
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic Focal Segmental Glomerulosclerosis: A Prospective Study of Acthar (PODOCYTE)
INTERVENTIONAL
Inicio: 10 de oct de 2016
ID: NCT02633046
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma (TIVO-1)
INTERVENTIONAL
Inicio: 1 de dic de 2009
ID: NCT01030783
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2/3 Trial to Evaluate the Glycemic Efficacy, Renal Safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00663260
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared With Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients With Heart Failure and Impaired Kidney Function
INTERVENTIONAL
Inicio: 12 de abr de 2024
ID: NCT06307652
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and Major Adverse Kidney Events in Participants With Body Mass Index ≥27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
INTERVENTIONAL
Inicio: 30 de abr de 2024
ID: NCT06383390
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind Clinical Trial to Evaluate the Safety and Tolerability of 24 Weeks Treatment With (50 mg qd) Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00646542
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects With Diabetic Kidney Disease
INTERVENTIONAL
Inicio: 18 de nov de 2019
ID: NCT04170543
Completado
Fase 4
ClinicalTrials.gov
CARMELINA: A Multicenter, International, Randomized, Parallel Group, Double-blind, Placebo-controlled, Cardiovascular Safety and Renal Microvascular Outcome Study With Linagliptin, 5 mg Once Daily in Patients With Type 2 Diabetes Mellitus at High Vascular Risk
INTERVENTIONAL
Inicio: 10 de jul de 2013
ID: NCT01897532
Terminado
Fase 3
ClinicalTrials.gov
An Open Label Study of the Safety, Tolerability and Effect on Hemoglobin Levels of Once-monthly Subcutaneous Mircera in Predialysis Patients With Chronic Renal Anemia Not Currently Treated With ESA.
INTERVENTIONAL
Inicio: 1 de abr de 2009
ID: NCT00680563
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.
INTERVENTIONAL
Inicio: 28 de jul de 2025
ID: NCT06858319
Anterior
1
...
7
8
9
...
434
Siguiente
Filtros